A detailed history of Chicago Partners Investment Group LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Chicago Partners Investment Group LLC holds 17,505 shares of NVO stock, worth $1.8 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
17,505
Previous 17,477 0.16%
Holding current value
$1.8 Million
Previous $2.49 Million 16.44%
% of portfolio
0.07%
Previous 0.1%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$119.07 - $145.42 $3,333 - $4,071
28 Added 0.16%
17,505 $2.08 Million
Q2 2024

Jul 31, 2024

BUY
$122.71 - $146.91 $10,184 - $12,193
83 Added 0.48%
17,477 $2.49 Million
Q1 2024

Apr 25, 2024

SELL
$102.11 - $135.92 $49,727 - $66,193
-487 Reduced 2.72%
17,394 $2.23 Million
Q4 2023

Feb 23, 2024

SELL
$87.78 - $105.45 $245,871 - $295,365
-2,801 Reduced 13.54%
17,881 $1.85 Million
Q3 2023

Oct 26, 2023

BUY
$90.94 - $199.54 $892,939 - $1.96 Million
9,819 Added 90.39%
20,682 $1.88 Million
Q2 2023

Aug 07, 2023

BUY
$155.98 - $172.65 $11,386 - $12,603
73 Added 0.68%
10,863 $1.76 Million
Q1 2023

Apr 26, 2023

BUY
$132.34 - $159.14 $97,931 - $117,763
740 Added 7.36%
10,790 $1.72 Million
Q4 2022

Feb 09, 2023

SELL
$102.55 - $135.33 $145,826 - $192,439
-1,422 Reduced 12.4%
10,050 $1.36 Million
Q2 2022

Aug 04, 2022

SELL
$103.24 - $121.81 $70,512 - $83,196
-683 Reduced 5.62%
11,472 $1.33 Million
Q1 2022

May 20, 2022

BUY
$93.1 - $112.54 $265,055 - $320,401
2,847 Added 30.59%
12,155 $1.26 Million
Q2 2021

Aug 02, 2021

SELL
$67.66 - $84.76 $81,192 - $101,712
-1,200 Reduced 11.42%
9,308 $831,000
Q1 2021

Apr 28, 2021

BUY
$67.06 - $75.82 $67,060 - $75,820
1,000 Added 10.52%
10,508 $779,000
Q4 2020

Jan 27, 2021

SELL
$63.89 - $73.8 $12,841 - $14,833
-201 Reduced 2.07%
9,508 $692,000
Q3 2020

Nov 06, 2020

BUY
$63.69 - $70.22 $200,623 - $221,193
3,150 Added 48.03%
9,709 $634,000
Q2 2020

Jul 31, 2020

BUY
$58.54 - $67.94 $6,322 - $7,337
108 Added 1.67%
6,559 $442,000
Q3 2019

Oct 31, 2019

BUY
$47.54 - $53.43 $306,680 - $344,676
6,451 New
6,451 $350,000
Q4 2018

Jan 11, 2019

SELL
$41.54 - $47.25 $130,601 - $148,554
-3,144 Closed
0 $0
Q3 2018

Nov 05, 2018

BUY
$46.76 - $51.24 $607 - $666
13 Added 0.42%
3,144 $134,000
Q2 2018

Aug 31, 2018

BUY
$44.29 - $50.42 $122,594 - $139,562
2,768 Added 762.53%
3,131 $144,000
Q1 2018

Apr 27, 2018

SELL
$48.49 - $58.14 $3,830 - $4,593
-79 Reduced 17.87%
363 $0
Q4 2017

Mar 28, 2018

SELL
$47.53 - $53.73 $380 - $429
-8 Reduced 1.78%
442 $0
Q3 2017

Nov 22, 2017

BUY
$41.15 - $49.22 $18,517 - $22,149
450
450 $0

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $232B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Chicago Partners Investment Group LLC Portfolio

Follow Chicago Partners Investment Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Partners Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Partners Investment Group LLC with notifications on news.